ROSWELL, Ga.--(BUSINESS WIRE)--CorMatrix® Cardiovascular Inc. is pleased to announce its first Veterans Health Administration Contract Award through its Federal distribution partner, Lovell Government Services LLC (LGS). The Contract award number #V797D-50450 enables the VA and other federal organizations to purchase any of the CorMatrix® products at pre-approved pricing via the Veterans Administration’s FSS Online Schedule.
“CorMatrix produces life-changing medical devices and technology that are now available via the online VA Federal Supply Schedule. I’m honored that CorMatrix selected LGS as their partner to help make these life-saving products readily available to the Veterans Healthcare System,” said Chris Lovell, President of LGS.
CorMatrix is approved for Cardiac Tissue Repair, Vascular Repair, Pericardial Repair and Reconstruction, and the CorMatrix CanGaroo™. CorMatrix products are made from decellularized porcine small intestinal submucosa. Extracellular matrix (ECM®) is the naturally occurring bioscaffold that surrounds cells in almost all tissues. CorMatrix acts as a scaffold into which the patient’s stem cells migrate and integrate — stimulating natural healing mechanisms which mature to form a strong, permanent tissue repair.
“While our primary focus has been in furthering the development of CorMatrix ECM technology and devices, we’re also focused on the need to ensure medical and surgical resources are made available to those who have served. We reached out to LGS in our effort to simplify and streamline Federal Contracting sales channels,” said CorMatrix CEO, David Camp. “We’re grateful to Chris for his service to our country and his desire to continue to serve by providing specialty devices such as CorMatrix to the Veterans Administration Hospital System and the U.S. Military Medical Networks.”
“By partnering with experts like LGS, we can help ensure CorMatrix products are being made available to our Veterans through the benefit network of the FSS and the hospitals that comprise the Veterans Health Administration,” added CFO of CorMatrix, John Thomas. “Mr. Lovell and his team will help us move toward our goal of making CorMatrix products a standard of care—not only for the brave men and women who have served, but for every patient who undergoes a vascular or cardiac procedure.”
CorMatrix® Cardiovascular, Inc. is a privately held medical device company dedicated to developing and delivering innovative biomaterial devices that harness the body’s own innate ability to repair damaged cardiac and vascular tissues. CorMatrix ECM Technology allows surgeons to restore the native anatomy of cardiac and vascular tissue in need of repair, serving as a superior alternative to synthetic or cross-linked materials. Headquartered in Roswell, Georgia, the Company is currently researching, developing and commercializing a platform technology known as CorMatrix ECM® for a variety of cardiovascular and other indications, and has U.S. clearance and European registration (with a CE Mark) for its ECM® technology. Since its launch in 2006, CorMatrix ECM Technology has been used at more than 975 hospitals across the U.S. and has been implanted in over 120,000 cardiac procedures. Visit cormatrix.com for additional information.
Lovell Government Services LLC (LGS) is a VA Certified Service Disabled Veteran Owned Small Business whose mission is to make leading edge Surgical and Medical resources more quickly and easily available to the Veterans Administration Hospital System and the U.S. Military Medical Networks via preferred Federal Contract Vehicles. If you would like more information regarding LGS, LLC please contact Chris Lovell at 850.684.1867 or email at email@example.com.